Microglia facilitate loss of perineuronal nets in the Alzheimer's disease brain

Joshua D Crapser1, Elizabeth E Spangenberg1, Rocio A Barahona1

  • 1Department of Neurobiology and Behavior, University of California, Irvine, CA 92697, USA.

Ebiomedicine
|August 4, 2020
PubMed
Abstract

Insights

Microglia contribute to Alzheimer's disease (AD) by driving the loss of perineuronal nets (PNNs), crucial neuronal structures. Preventing microglial activation protects PNNs and may offer a therapeutic avenue for AD.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Microglia, the brain's immune cells, are implicated in Alzheimer's disease (AD) pathogenesis.
  • The role of microglia in modulating perineuronal nets (PNNs) in AD is unclear.
  • PNNs are extracellular matrix structures stabilizing neuronal synapses, and their alteration in AD is debated.

Purpose of the Study:

  • To investigate the relationship between microglia, amyloid plaques, and PNNs in Alzheimer's disease.
  • To determine if microglia-mediated neuroinflammation contributes to PNN loss in AD.
  • To assess the therapeutic potential of targeting microglia to preserve PNNs in AD models.

Main Methods:

  • Histological analysis of PNNs, microglia, and amyloid plaques in 5xFAD mice and human AD tissue.
  • Investigated neuroinflammation's role using LPS treatment.
  • Assessed PNN preservation by depleting microglia with a CSF1R inhibitor (PLX5622) in AD mouse models.

Main Results:

  • PNNs are extensively lost in AD brains, correlating with plaque burden.
  • Activated microglia engulf PNN material, and aggrecan deposits in human plaques.
  • Microglial depletion prevents PNN loss in AD models, despite persistent plaques.
  • PNN degradation precedes neuronal loss in parvalbumin interneurons.

Conclusions:

  • Phenotypically altered microglia drive plaque-dependent PNN loss in the AD brain.
  • Targeting microglia may prevent PNN degradation and mitigate AD-related neurodegeneration.